Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes Medical Dialogues Bureau21 Sep 2019 4:00 AM GMT'We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,' said...
